You are here: Industry Insights > recall

News List

Glenmark Recalls All Unexpired Lots of its Ranitidine Tablets, Ceases Distribution americanpharmaceuticalreview
December 19, 2019
Glenmark Pharmaceutical announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level.
Sandoz voluntarily recalls ranitidine over NDMA contamination concerns europeanpharmaceuticalreview
September 27, 2019
The probable carcinogen N-nitrosodimethylamine was detected in Sandoz’s ranitidine capsules, prompting the voluntary move.
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity worldpharmanews
September 26, 2019
The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc. ...
Losartan drug recall expanded to include five more lots europeanpharmaceuticalreview
September 26, 2019
FDA announces the voluntary recall for the losartan medications has been extended to include more lots, after impurities were found in the drugs.
Takeda Issues US Recall of NATPARA americanpharmaceuticalreview
September 09, 2019
Takeda Pharmaceutical announced the company is issuing a US recall for all doses of NATPARA® (parathyroid hormone) for Injection (25 mcg, 50 mcg, 75 mcg, and 100 mcg).
AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab americanpharmaceuticalreview
September 05, 2019
AmEx Pharmacy has announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable...
Pfizer Issues Recall for 2 Lots of RELPAX americanpharmaceuticalreview
August 19, 2019
Pfizer is voluntarily recalling RELPAX® (eletriptan hydrobromide) 40 mg tablets, lots AR5407 and CD4565, to the Patient level. Pfizer Inc. initiated this recall because these product lots may not meet Pfizer’s in-house microbiological specification for ..
Jubilant Cadista Issues Recall of Drospirenone, Ethinyl Estradiol Tablets americanpharmaceuticalreview
July 25, 2019
Jubilant Cadista Pharmaceuticals is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level.
Altaire Issues Recall of Multiple Ophthalmic Products Sold At CVS americanpharmaceuticalreview
July 17, 2019
Altaire Pharmaceuticals announced it is voluntarily recalling the Over-the-Counter (OTC) drug products and lots, within expiry, sold at CVS Health the during the time period as indicated on the FDA website.
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold at Wal Mart drugs
July 15, 2019
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold at Wal Mart.

Previous page 1 2 3 4 5 6 7 8 Next page